Lapatinib, Di-p-Toluenesulfonate Salt (N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine Ditosylate, Lapatinib Ditosylate, Tykerb, GW-572016, Tyverb), CAS [[38808

Catalog Number: USB-L1315-50
Article Name: Lapatinib, Di-p-Toluenesulfonate Salt (N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine Ditosylate, Lapatinib Ditosylate, Tykerb, GW-572016, Tyverb), CAS [[38808
Biozol Catalog Number: USB-L1315-50
Supplier Catalog Number: L1315-50
Alternative Catalog Number: USB-L1315-50-100
Manufacturer: US Biological
Category: Molekularbiologie
Lapatinib inhibits both epidermal growth factor receptor (EGFR) and HER2/neu (ErbB-2) tyrosine kinases by binding to the intracellular phosphorylation domain, preventing receptor autophosphorylation. The exact site of binding has currently not been confirmed. It appears to arrest the development of breast cancer in some patients with metastatic, treatment-refractory disease. Solubility: Soluble in DMSO at 200mg/ml, very poorly soluble in ethanol, very poorly soluble in water, maximum solubility in plain water is estimated to be about 1-10uM, buffers, serum, or other additives may increase or decrease the aqueous solubility. Elemental Anaylsis: Calculated: C=54.22% H=4.76% Cl=3.72% F= 1.99% N=5.88% S= 10.10% Storage and Stability: Lyophilized powder may be stored at -20C. Stable for 6 months after receipt.
Molecular Weight: 925.46
Purity: ~99%
Form: Supplied as a yellow powder.
CAS Number: [388082-78-8]